On Oct 04, major Wall Street analysts update their ratings for $CME Group (CME.US)$, with price targets ranging from $180 to $275.
Goldman Sachs analyst Alexander Blostein maintains with a sell rating, and adjusts the target price from $201 to $198.
BofA Securities analyst Craig Siegenthaler maintains with a sell rating, and adjusts the target price from $177 to $180.
Citi analyst Christopher Allen maintains with a buy rating, and adjusts the target price from $240 to $250.
UBS analyst Alex Kramm maintains with a buy rating, and adjusts the target price from $250 to $275.
Furthermore, according to the comprehensive report, the opinions of $CME Group (CME.US)$'s main analysts recently are as follows:
Lower interest rates and a slow recovery in deal activity present downside risks across most capital markets stocks as Q3 reports approach. Although faster rate cuts and stronger equity markets have encouraged risk-on behavior, sluggish deal rates persist as a headwind for many alternative managers amidst valuations that are considered very high. Traditional managers have seen organic growth worsen in the third quarter, and lower interest rates pose a significant threat to the earnings of brokers and wealth managers. Exchanges and trust banks are seen as relatively positive aspects in the context of Q3 outcomes.
The company's trading activity in Q3 has been characterized as 'robust'. Looking forward, the volume outlook is perceived as solid, and the company is expected to be well positioned to benefit from its asset diversity and the depth of liquidity on its platform.
Here are the latest investment ratings and price targets for $CME Group (CME.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月4日，多家华尔街大行更新了$芝加哥商品交易所 (CME.US)$的评级，目标价介于180美元至275美元。
高盛集团分析师Alexander Blostein维持卖出评级，并将目标价从201美元下调至198美元。
美银证券分析师Craig Siegenthaler维持卖出评级，并将目标价从177美元上调至180美元。
花旗分析师Christopher Allen维持买入评级，并将目标价从240美元上调至250美元。
瑞士银行分析师Alex Kramm维持买入评级，并将目标价从250美元上调至275美元。
此外，综合报道，$芝加哥商品交易所 (CME.US)$近期主要分析师观点如下：
随着第三季度报告的临近，较低的利率和交易活动的缓慢复苏给大多数资本市场股票带来了下行风险。尽管更快的降息和更强劲的股市鼓励了冒险行为，但在估值被认为很高的情况下，低迷的交易利率仍然是许多另类管理公司的不利因素。传统管理人看到第三季度的有机增长恶化，较低的利率对经纪商和财富管理公司的收益构成重大威胁。在第三季度业绩的背景下，交易所和信托银行被视为相对积极的方面。
该公司在第三季度的交易活动被描述为 “强劲”。展望未来，交易量前景被认为是稳健的，预计该公司将处于有利地位，可以从其资产多样性和平台的流动性深度中受益。
以下为今日4位分析师对$芝加哥商品交易所 (CME.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
